Takara Bio Inc. Overview
Pro stress-test →Takara Bio is a biotechnology company that develops and researches reagents for genome engineering and analysis, the technology used for gene therapy and natural health food products. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio.
Strategic Profile
Pro stress-test →Takara Bio became the first company in Japan to conduct clinical trials of gene therapy products in 2008 and entered the CDMO business early, operating the Center for Gene and Cell Processing (CGCP), a large-scale one-stop center for development, manufacturing, and quality testing of gene therapy products. The company develops and delivers products tailored to local researchers through manufacturing centers in the U.S., Europe, China, and India, along with a global sales network.
Competitive Landscape
Pro stress-test →Takara Bio competes in the biotechnology research reagent and gene therapy manufacturing space against companies like Thermo Fisher, FUJIFILM Cellular Dynamics, and emerging CDMO players. Its competitive advantages include early entry into Japan's gene therapy market, established CDMO infrastructure, and a comprehensive portfolio of research reagents.
Industry Context
Takara Bio Inc. operates in Biotechnology & Gene Therapy.
Key facts
Founded: 2002 · Headquarters: Kusatsu, Japan · Employees: 1,779 · Revenue: $311.7M · Market cap: $891.6M